ADO 0.00% 2.6¢ anteotech ltd

From FDA Clinical studiesAlthough several clinical trials are...

  1. 6 Posts.
    lightbulb Created with Sketch. 2
    From FDA Clinical studies
    Although several clinical trials are now underway to test possible therapies, the worldwide response to the COVID-19 outbreak has been largely limited to monitoring/containment. We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addition to Vero-hSLAM cells 2 h post infection with SARS-CoV-2 able to effect ~5000-fold reduction in viral RNA at 48 h. Ivermectin therefore warrants further investigation for possible benefits in humans.

    So a balanced conversation .I don't care either way but some people swallow anything ,like you dd.
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.6¢
Change
0.000(0.00%)
Mkt cap ! $64.73M
Open High Low Value Volume
2.6¢ 2.6¢ 2.5¢ $34.35K 1.322M

Buyers (Bids)

No. Vol. Price($)
3 114142 2.6¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 530000 2
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.